Track topics on Twitter Track topics that are important to you
]]>(MedPage Today) -- New data for patients with HER2-positive early stage breast cancer were reported in two important studies at the recent 2019 San Antonio Breast Cancer Symposium. APHINITY compared chemotherapy plus trastuzumab (Herceptin) to...
Original Article: APHINITY and ATEMPT: Treating Early-Stage HER2+ Breast CancerNEXT ARTICLE
Track and monitor developments in breast cancer research and commercial development. Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...